4.6 Article

Resting-State Functional Connectivity Predicts Cognitive Impairment Related to Alzheimer's Disease

Journal

FRONTIERS IN AGING NEUROSCIENCE
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2018.00094

Keywords

aging; Alzheimer's disease; mild cognitive impairment; functional connectivity; resting state

Funding

  1. NIH [MH108591]
  2. US National Science Foundation Graduate Research Fellowship
  3. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  4. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  5. National Institute on Aging
  6. National Institute of Biomedical Imaging and Bioengineering
  7. AbbVie
  8. Alzheimer's Association
  9. Alzheimer's Drug Discovery Foundation
  10. Araclon Biotech
  11. BioClinica, Inc.
  12. Biogen
  13. Bristol-Myers Squibb Company
  14. CereSpir, Inc.
  15. Cogstate
  16. Eisai Inc.
  17. Elan Pharmaceuticals, Inc.
  18. Eli Lilly and Company
  19. EuroImmun
  20. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  21. Fujirebio
  22. GE Healthcare
  23. IXICO Ltd.
  24. Janssen Alzheimer Immunotherapy Research and Development, LLC.
  25. Johnson and Johnson Pharmaceutical Research and Development LLC.
  26. Lumosity
  27. Lundbeck
  28. Merck and Co., Inc.
  29. Meso Scale Diagnostics, LLC.
  30. NeuroRx Research
  31. Neurotrack Technologies
  32. Novartis Pharmaceuticals Corporation
  33. Pfizer Inc.
  34. Piramal Imaging
  35. Servier
  36. Takeda Pharmaceutical Company
  37. Transition Therapeutics
  38. Canadian Institutes of Health Research
  39. Northern California Institute for Research and Education

Ask authors/readers for more resources

Resting-state functional connectivity (rs-FC) is a promising neuromarker for cognitive decline in aging population, based on its ability to reveal functional differences associated with cognitive impairment across individuals, and because rs-fMRI may be less taxing for participants than task-based fMRI or neuropsychological tests. Here, we employ an approach that uses rs-FC to predict the Alzheimer's Disease Assessment Scale (11 items; ADAS11) scores, which measure overall cognitive functioning, in novel individuals. We applied this technique, connectome-based predictive modeling, to a heterogeneous sample of 59 subjects from the Alzheimer's Disease Neuroimaging Initiative, including normal aging, mild cognitive impairment, and AD subjects. First, we built linear regression models to predict ADAS11 scores from rs-FC measured with Pearson's r correlation. The positive network model tested with leave-one-out cross validation (LOOCV) significantly predicted individual differences in cognitive function from rs-FC. In a second analysis, we considered other functional connectivity features, accordance and discordance, which disentangle the correlation and anticorrelation components of activity timecourses between brain areas. Using partial least square regression and LOOCV, we again built models to successfully predict ADAS11 scores in novel individuals. Our study provides promising evidence that rs-FC can reveal cognitive impairment in an aging population, although more development is needed for clinical application. Introduction.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available